J Štěpán

ASSESSMENT OF FRACTURE RISK AND ITS APPLICATION TO SCREENING FOR POSTMENOPAUSAL OSTEOPOROSIS

Ludmila P. Alexeeva, Patrick Burkhardt, C. Christiansen et al. · 1994 · 2.7K citations

Bone Disease, Skeletal Trauma, Bone Health +5

Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

Jane A. Cauley, Larry Norton, Marc E. Lippman et al. · Breast Cancer Research and Treatment · 2001 · 680 citations

Breast Oncology, Oncology, More Trial +12

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

H. A. P. Pols, Dieter Felsenberg, David A. Hanley et al. · Osteoporosis International · 1999 · 594 citations

Bone Disease, Bone Health, Low Bone Mass +8

Castrated Men Exhibit Bone Loss: Effect of Calcitonin Treatment on Biochemical Indices of Bone Remodeling*

J Štěpán, M Lachman, JAN ZVĚŘINA et al. · The Journal of Clinical Endocrinology & Metabolism · 1989 · 430 citations

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

Reginster Jy, S. Adámi, Péter L. Lakatos et al. · Annals of the Rheumatic Diseases · 2005 · 329 citations · Full text

Bone Disease, Once-monthly Oral Ibandronate, Bone Health +8